MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Substance Abuse, Substance Use Disorder (SUD)_Opioid, Alcohol, Tobacco, Etc.
Brainsway Ltd (NASDAQ:BWAY)
Organization & Developments: Brainsway
Parents
Brainsway Ltd (NASDAQ:BWAY)
Children
*Brainsway Ltd. engages in the development and provision of technology solutions for non-invasive treatment of brain disorders in Israel and internationally.
*Brainsway, Ltd (Brainsway Deep Transcrainal Magnetic Stimulation (DTMS) Device)
*Focused on the development and sale of neuromodulation devices for the treatment of psychiatric, neurological and addictive disorders using their proprietary deep transcranial magnetic stimulation (TMS).
*Results from clinical trials treating Post-Traumatic Stress Disorder (PTSD) and nicotine addiction (expected in the 2H 2019) or reimbursement approval for the treatment of Obsessive-Compulsive Disorder (OCD) could be catalysts for a significant repricing of the company
2011: Brainsway wins Israeli nod for deep-brain stimulation device to treat depression (2011)
2019: Brainsway: Deep TMS, Deep Undervaluation_seekingalpha.com
2020: Brainsway: Lockdowns Are Hiding Progress In The Business
2020: Brainsway: Still Undervalued
2023: BrainsWay: Parabolic Stock Warrants Context And Caution_ seekingalpha.com
2023: BrainsWay: Positive Cash Flow And Continued Growth_ seekingalpha.com
2024: BrainsWay Is Reviving From A Deep Depression_seekingalpha.com
2024: BrainsWay Q4 Earnings Preview
2024: BrainsWay: Operating Leverage Driving Upside
2024: BrainsWay: Profitable, Growing, And Cheap
Jumps
*Key People: Brainsway
Finance & Acquisition: Brainsway